Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
O6-甲基鸟嘌呤-DNA 甲基转移酶 (MGMT) 启动子甲基化检测对预测接受替莫唑胺治疗的胶质母细胞瘤患者总体生存率的预后价值
期刊:Cochrane Database of Systematic Reviews
影响因子:8.8
doi:10.1002/14651858.CD013316.pub2
Alexandra McAleenan, Claire Kelly, Francesca Spiga, Ashleigh Kernohan, Hung-Yuan Cheng, Sarah Dawson, Lena Schmidt, Tomos Robinson, Sebastian Brandner, Claire L Faulkner, Christopher Wragg, Sarah Jefferies, Amy Howell, Luke Vale, Julian P T Higgins, Kathreena M Kurian